BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38251573)

  • 1. Exploratory analysis of the TREAT EARLIER trial: is the efficacy of temporary methotrexate treatment dose-dependent?
    Krijbolder DI; Boom HD; van der Helm-van Mil AHM
    Lancet Rheumatol; 2023 Aug; 5(8):e437-e439. PubMed ID: 38251573
    [No Abstract]   [Full Text] [Related]  

  • 2. To treat or not to treat? Current attitudes on treatment aimed at modifying the disease burden in clinically suspect arthralgia: a survey among participants of the TREAT EARLIER trial and healthcare professionals.
    Krijbolder DI; Khidir SJH; van der Helm-van Mil AH
    RMD Open; 2023 Aug; 9(3):. PubMed ID: 37532468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Historical perspective on the use of methotrexate for the treatment of rheumatoid arthritis.
    Ward JR
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():3-6. PubMed ID: 3913774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate: a drug of the future in ulcerative colitis?
    Carbonnel F
    Curr Drug Targets; 2011 Sep; 12(10):1413-6. PubMed ID: 21466494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003459. PubMed ID: 15674908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate for the treatment of chronic corticosteroid-dependent asthma.
    Reid DJ; Segars LW
    Clin Pharm; 1993 Oct; 12(10):762-7. PubMed ID: 8258256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2003; (1):CD003459. PubMed ID: 12535475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of methotrexate in comparison to biologics in rheumatoid arthritis.
    Rau R
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S58-64. PubMed ID: 21044435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and clinical studies of 24-h infusions of high-dose methotrexate.
    Cohen HJ; Jaffe N
    Cancer Chemother Pharmacol; 1978; 1(1):61-4. PubMed ID: 373909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate in the treatment of penile carcinoma.
    Sklaroff RB; Yagoda A
    Cancer; 1980 Jan; 45(2):214-6. PubMed ID: 6985829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate (MTX) underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis?
    Pincus T; Bergman MJ; Yazici Y
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S82-93. PubMed ID: 26472658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy and incremental cost per responder of methotrexate versus apremilast for methotrexate-naïve patients with psoriasis.
    Armstrong AW; Betts KA; Sundaram M; Thomason D; Signorovitch JE
    J Am Acad Dermatol; 2016 Oct; 75(4):740-746. PubMed ID: 27476973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting.
    Alten R; Burkhardt H; Feist E; Krüger K; Rech J; Rubbert-Roth A; Voll RE; Elbez Y; Rauch C
    Arthritis Res Ther; 2018 Jan; 20(1):1. PubMed ID: 29329602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Wang Y; Tsoulis DJ; MacDonald JK; Feagan BG
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD003459. PubMed ID: 25099640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of parenteral methotrexate compared with sodium aurothiomalate (Myochrysine) in the treatment of rheumatoid arthritis.
    Suarez-Almazor ME; Fitzgerald A; Grace M; Russell AS
    J Rheumatol; 1988; 15(5):753-6. PubMed ID: 3139877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short term efficacy of methotrexate in the treatment of rheumatoid arthritis.
    Willkens RF
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():21-4. PubMed ID: 3913772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I trial of high-dose methotrexate with modified citrovorum factor rescue.
    Jacobs SA; Santicky MJ
    Cancer Treat Rep; 1978 Mar; 62(3):397-9. PubMed ID: 348306
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of folates concomitantly with low-dose pulse methotrexate.
    Shiroky JB
    Rheum Dis Clin North Am; 1997 Nov; 23(4):969-80. PubMed ID: 9361164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate in the treatment of systemic glucocorticoid-dependent severe persistent asthma: a word of caution.
    Fabbri L; Caramori G; Cosma P; Ciaccia A
    Monaldi Arch Chest Dis; 1996 Apr; 51(2):130-7. PubMed ID: 8680380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.